age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
79.07495
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| null | null | null | 10.5
|
black
| 20.398438
| 43
| 0.796997
| 0.72998
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 97
| 21.699219
| 75
| 28
| 37.19531
| 240.8125
| 3.299805
| 0.599976
| 9
| 140
| 7.399414
| null | null | null | null | null | null | 2.741211
| 989
| 1
|
72.70398
|
male
| 0
| 77
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 108,508.375
| 77,681.375
| null | 27
|
white
| 34.09375
| 69
| 0.511963
| 0.394958
| 4
| 1
| 0
|
no
| null | null |
no dnr
| 77
| 81
| 14.798828
| 110
| 32
| 38
| 140
| 1.899902
| 0.299988
| 2.899902
| 128
| 7.25
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 833
| 1
|
44.90598
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
| null | 0
| 38,080.625
| 25,337.0625
| null | 27
|
black
| 32.59375
| 49
| 0.747925
| 0.668945
| 1
| 0
| 0
|
no
| 0.9
| 0.78
|
no dnr
| 17
| 121
| 14.798828
| 116
| 35
| 36.79688
| 155
| null | 1
| 2.799805
| 139
| 7.489258
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 338
| 1
|
50.75198
|
male
| 0
| 40
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 61,610.688
| 42,038.8438
| null | 28.5
|
black
| 34.09375
| 51
| 0.709961
| 0.549927
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 40
| 55
| 8.398438
| 138
| 40
| 39
| 330
| 2.799805
| 1.5
| 1.5
| 129
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 86
| 1
|
83.33997
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 16
|
under $11k
| 0
| 1,314.449
| 1,066.7598
| null | 16
|
black
| 14.199219
| 17
| 0.837891
| 0.733887
| 1
| 0
| 0
|
yes
| 0.95
| 0.75
|
no dnr
| 3
| 93
| 5.799805
| 80
| 20
| 36.39844
| null | null | 0.899902
| 1.199951
| 141
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,443
| 1
|
56.27399
|
female
| 1
| 21
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 61
| 72,193.188
| 48,118.1875
| null | 43.333313
|
black
| 29.398438
| 40
| 0.575928
| 0.381958
| 1
| 0
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 19
| 110
| 10
| 148
| 8
| 36.29688
| 300
| null | 3.799805
| 1.799805
| 130
| 7.379883
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 21
| 1
|
72.56097
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 8,884.898
| 6,848.4844
| null | 15.5
|
black
| 19.199219
| 31
| 0.8479
| 0.750977
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 103
| 4.699219
| 82
| 24
| 37
| 223.3125
| 3.199707
| null | 2
| 136
| 7.389648
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 1,804
| 0
|
45.14398
|
male
| 0
| 113
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
| null | 44
| 116,927.5
| 88,552.1875
| null | 27.25
|
black
| 23.796875
| 29
| 0.712891
| 0.625977
| 6
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 113
| 135
| 24.699219
| 114
| 30
| 38.09375
| 188.5625
| null | null | 0.899902
| 147
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,803
| 0
|
65.65399
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| null | null | null | 12
|
white
| 13.5
| 21
| 0.914917
| 0.855957
| 1
| 0
| 0
|
no
| 0.75
| 0.421875
|
no dnr
| 5
| 69
| 5.299805
| 72
| 20
| 36.29688
| 328.5625
| 3.599609
| 0.599976
| 1.099854
| 141
| 7.369141
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 225
| 1
|
28.66299
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 37
| 44,095.188
| 29,580.2344
| null | 49
|
black
| 32.695313
| 77
| 0.332947
| 0.217987
| 2
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 7
| 67
| 0.399963
| 144
| 32
| 38.89844
| 226
| 2.199707
| 2.399902
| 1.699951
| 143
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.28125
| 7
| 1
|
69.85596
|
female
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 0
| 111,948.75
| 76,592.375
| null | 24.5
|
black
| 37.09375
| 57
| 0.504883
| 0.387939
| 1
| 0
| 0
|
no
| 0.25
| 0.15
|
no dnr
| 62
| 61
| 1.399902
| 130
| 26
| 37.79688
| 144.28125
| null | 0.399963
| 1.599854
| 129
| 7.449219
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,801
| 0
|
64.56897
|
female
| 1
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 11
| null | 44
| 65,322.344
| 43,567.9688
| null | 33
|
white
| 30.296875
| 42
| 0.223999
| 0.125977
| 10
| 0
| 0
|
yes
| 0.15
| 0.1
|
dnr after sadm
| 6
| 129
| 11.298828
| 118
| 37
| 37.79688
| 380
| null | 0.799927
| 3.799805
| 153
| 7.329102
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
69.39398
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 61
| null | null | null | 40
|
white
| 26.796875
| 43
| 0.407959
| 0.28894
| 7
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 125
| 17.199219
| 180
| 36
| 38.89844
| 420
| null | null | 0.5
| 133
| 7.519531
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 4
| 1
|
51.61398
|
female
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 6,321.5
| 4,776.6172
| null | 8
|
white
| 26.796875
| 26
| 0.728882
| 0.575928
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 8
| 80
| 5.099609
| 100
| 24
| 36.79688
| 523.75
| null | 20.097656
| 0.799927
| 133
| 7.619141
| null | null | null | 5
| 5
|
adl>=4 (>=5 if sur)
| 5
| 1,799
| 0
|
69.02899
|
male
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
| null | 0
| 50,995.469
| 35,083.5312
| null | 21
|
white
| 36.59375
| 68
| 0.248993
| 0.145996
| 13
| 0
| 0
|
yes
| 0.7
| 0.4
|
no dnr
| 18
| 70
| 0.199982
| 104
| 42
| 36.09375
| 142.5
| 1.899902
| null | 1.199951
| 132
| 7.55957
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 210
| 1
|
77.99298
|
female
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
|
under $11k
| 0
| 97,410.875
| 63,252.7812
| null | 39
|
white
| 38.296875
| 57
| 0.311951
| 0.198975
| 10
| 0
| 0
|
no
| null | null |
dnr after sadm
| 16
| 59
| 24.097656
| 130
| 12
| 38.09375
| 70
| 2.5
| 0.899902
| 3.299805
| 132
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
28.465
|
female
| 0
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 175,319.625
| 116,491.938
| null | 45.75
|
white
| 32.5
| 64
| 0.809937
| 0.746948
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 59
| 111
| 30.199219
| 150
| 24
| 37.79688
| 112.71875
| 2.899902
| 0.299988
| 5.899414
| 142
| 7.40918
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,800
| 0
|
54.409
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 5,722.949
| 4,023.6309
| null | 16
|
black
| 16
| 20
| 0.75
| 0.490967
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 6
| 117
| 8.099609
| 62
| 18
| 36.89844
| null | null | 0.5
| 1.5
| 136
| null | null | null | null | null | null | null | 2.001953
| 1,017
| 1
|
72.85095
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 8,237.742
| 5,929.5586
| null | 13
|
white
| 17.796875
| 15
| 0.852905
| 0.757935
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 10
| 100
| 6.699219
| 100
| 22
| 36.59375
| 285.6875
| 3.399902
| 0.399963
| 0.699951
| 144
| 7.449219
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,798
| 0
|
62.439
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 8,158.945
| 5,384.2227
| null | 6
|
black
| 16.5
| 20
| 0.7229
| 0.447998
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 7
| 76
| 8
| 100
| 24
| 36.29688
| 271.375
| null | 0.799927
| 1.099854
| 140
| 7.459961
| null | null | null | null | null | null | 2.696289
| 411
| 1
|
50.41498
|
male
| 1
| 11
|
Lung Cancer
|
Cancer
| 1
| 13
|
$25-$50k
| 0
| 7,345.949
| 5,915.4453
| null | 8.5
|
white
| 24.199219
| 18
| 0.582886
| 0.262939
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.01
|
dnr after sadm
| 7
| 77
| 6.5
| 120
| 24
| 36
| null | 3.099609
| 0.599976
| 1
| 138
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
42.56497
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
|
under $11k
| 0
| 20,683.688
| 13,962.1172
| null | 37
|
white
| 29.097656
| 50
| 0.540894
| 0.426941
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.15
|
dnr after sadm
| 2
| 120
| 29.097656
| 160
| 31
| 38.69531
| 113.32812
| 3.699707
| null | 1.099854
| 137
| 7.399414
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 7
| 1
|
69.93799
|
male
| 1
| 10
|
Coma
|
Coma
| 1
| 8
|
under $11k
| 100
| 26,657.688
| 18,507.6094
| null | 33
|
black
| 33.796875
| 44
| 0.017998
| 0.007
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 69
| 19.597656
| 130
| 22
| 40
| 147.5
| null | 0.5
| 3.699707
| 146
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
56.452
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 5,301.496
| 4,523.5391
| null | 12.5
|
black
| 20.296875
| 42
| 0.880981
| 0.80188
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 75
| 9.398438
| 72
| 20
| 36.29688
| 271.375
| 3.799805
| 0.599976
| 5.399414
| 133
| 7.379883
| null | null | null | null | null | null | 2.793457
| 402
| 1
|
65.08997
|
male
| 0
| 134
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 361,896
| 240,649.75
| null | 48.5
|
white
| 39.898438
| 76
| 0.119995
| 0.052994
| 29
| 0
| 0
|
no
| 0.75
| 0.421875
|
dnr after sadm
| 3
| 120
| 29.199219
| 118
| 36
| 35.79688
| 156.65625
| 2.899902
| 4.5
| 5.399414
| 134
| 7.359375
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 585
| 1
|
42.02899
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 14
|
$11-$25k
| 0
| 5,846.648
| 3,857.8223
| null | 16
|
white
| 14.898438
| 5
| 0.791992
| 0.560913
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.5
|
no dnr
| 6
| 80
| 6.699219
| 78
| 16
| 36
| null | null | 0.199982
| 0.799927
| 139
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 186
| 1
|
21.13599
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 31,238.188
| 21,454.6875
| null | 17.333328
|
white
| 24.699219
| 28
| 0.883911
| 0.841919
| 1
| 0
| 0
|
yes
| 0.2
| 0.2
|
no dnr
| 14
| 135
| 2.899902
| 62
| 32
| 37.79688
| 384
| null | 2.599609
| 0.599976
| 136
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,796
| 0
|
70.88599
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 26
| 68,258
| 48,212.6875
| null | 26.5
|
white
| 28.898438
| 47
| 0.595947
| 0.487976
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 35
| 55
| 11.398438
| 56
| 10
| 35.5
| 134
| 1.199951
| 0.5
| 1.299805
| 142
| 7.449219
| null | null | null | null | 5
|
SIP>=30
| 5
| 1,796
| 0
|
63.28799
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 0
| 88,884
| 58,544.5312
| null | 42
|
white
| 39.796875
| 67
| 0.473999
| 0.35498
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 17
| 57
| 19
| 134
| 30
| 38.19531
| 88
| null | 0.899902
| 4.5
| 133
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
70.81494
|
female
| 1
| 17
|
Coma
|
Coma
| 1
| 2
|
under $11k
| 44
| 42,977.75
| 30,679.125
| null | 32
|
black
| 26.296875
| 36
| 0.365967
| 0.291992
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 15
| 55
| 19.097656
| 64
| 8
| 36.59375
| 383.3125
| null | null | 2.399902
| 150
| 7.429688
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
67.66895
|
male
| 1
| 10
|
Coma
|
Coma
| 0
| 4
|
under $11k
| 37
| 39,055.375
| 26,184.4531
| null | 50
|
white
| 45.296875
| 100
| 0.021
| 0.008999
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 40
| 27.597656
| 150
| 30
| 40.19531
| 228
| null | 3.099609
| 9.798828
| 131
| 7.30957
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
47.03897
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 3,280.449
| 2,724.5938
| null | 15
|
white
| 21.699219
| 28
| 0.832886
| 0.727905
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 92
| 8
| 100
| 24
| 36.5
| null | 1.799805
| 2.599609
| 0.699951
| 130
| null | null | null | null | 1
| null | null | 1.1669
| 1,794
| 0
|
77.18799
|
male
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 2
| null | 0
| 25,724.891
| 17,758.4375
| null | 24.333328
|
other
| 21.597656
| 35
| 0.775879
| 0.642944
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 70
| 7.699219
| 142
| 8
| 38.09375
| 194.28125
| 3.299805
| 1.099854
| 1.199951
| 144
| 7.399414
| null | null | null | null | null | null | 2.947266
| 1,794
| 0
|
49.23798
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 8
|
$11-$25k
| 0
| 5,958.297
| 4,430.75
| null | 11
|
white
| 23.898438
| 34
| 0.791992
| 0.665894
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 60
| 4
| 72
| 20
| 35.5
| 500
| 2.799805
| 8
| 0.899902
| 133
| 7.449219
| null | null | null | 4
| 0
|
no(M2 and SIP pres)
| 0
| 1,785
| 0
|
62.68597
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 5,468.949
| 3,953.1797
| null | 9
|
white
| 20.699219
| 20
| 0.765991
| 0.516968
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 6
| 107
| 5.599609
| 120
| 24
| 35.59375
| null | null | 0.599976
| 1.099854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,178
| 1
|
68.03296
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 11,001.445
| 7,942.6523
| null | 11.5
|
black
| 18.898438
| 27
| 0.861938
| 0.771973
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 7
| 127
| 16.898438
| 68
| 26
| 35.79688
| 284
| null | 0.399963
| 1.199951
| 141
| 7.419922
| null | null | null | null | null | null | 2.250488
| 1,785
| 0
|
89.76294
|
male
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 0
|
under $11k
| 0
| 63,745.625
| 44,125.3438
| null | 41
|
black
| 28.898438
| 62
| 0.601929
| 0.494995
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
dnr after sadm
| 19
| 62
| 7.699219
| 58
| 4
| 35.29688
| 438.0625
| 2.399902
| null | 4.099609
| 136
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
54.30798
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
|
$25-$50k
| 0
| 22,134.484
| 15,105.8516
| null | 39
|
white
| 27.199219
| 45
| 0.764893
| 0.689941
| 4
| 1
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 68
| 18.5
| 122
| 8
| 38.09375
| 188
| 2.099609
| 2.199707
| 0.799927
| 160
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
48.586
|
male
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 6
|
$11-$25k
| 0
| 132,172.5
| 88,508.3125
| null | 37.75
|
white
| 28
| 30
| 0.805908
| 0.740967
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 45
| 103
| 23.097656
| 132
| 28
| 39.39844
| 192.5
| null | 2.699707
| 1.199951
| 149
| 7.439453
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,784
| 0
|
64.28198
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
|
$25-$50k
| 0
| 6,832.246
| 5,436.1875
| null | 3.5
|
white
| 13.699219
| 27
| 0.915894
| 0.858887
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 11
| 97
| 6
| 76
| 28
| 36.29688
| 495.1875
| 4.399414
| 0.699951
| 2
| 139
| 7.429688
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 809
| 1
|
65.40997
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 6
| null | 0
| 5,862.547
| 4,109.2969
| null | 11
|
white
| 14.5
| 9
| 0.753906
| 0.496948
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 5
| 119
| 5.099609
| 72
| 20
| 36.89844
| null | 3.399902
| 0.599976
| 0.899902
| 141
| null | null | null | null | 0
| null | null | 0.4948
| 67
| 1
|
68.159
|
male
| 1
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 4,788.25
| 3,870.5644
| null | 8.5
|
white
| 19.699219
| 30
| 0.85498
| 0.761963
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 72
| 7.099609
| 84
| 24
| 35.89844
| null | null | null | 1.799805
| 133
| null | null | null | null | 2
| 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
76.28198
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 3,523.699
| 3,085.0391
| null | 3.5
|
black
| 17.597656
| 22
| 0.666992
| 0.366943
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 8
| 107
| 7.599609
| 68
| 16
| 35.19531
| null | null | null | 1
| 137
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.051758
| 24
| 1
|
24.54999
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 37
| 39,816.438
| 25,422.2656
| null | 43
|
white
| 31.097656
| 71
| 0.326965
| 0.211975
| 7
| 0
| 0
|
yes
| 0
| 0
|
no dnr
| 6
| 130
| 0.099991
| 150
| 55
| 37.89844
| 381
| 2.699707
| 0.5
| 1.099854
| 137
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 2.190918
| 6
| 1
|
68.40198
|
female
| 0
| 36
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 12
|
under $11k
| 0
| 85,186.938
| 52,831.0312
| null | 15.25
|
white
| 14.599609
| 13
| 0.901978
| 0.834961
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 36
| 93
| 6.599609
| 80
| 20
| 36.39844
| null | null | 0.599976
| 1.099854
| 134
| null | null | null | null | 0
| 0
| null | 0
| 1,778
| 0
|
65.45898
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 8,641.648
| 6,417.7227
| null | 9.5
|
white
| 32.695313
| 59
| 0.460999
| 0.258972
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 8
| 73
| 8.099609
| 100
| 24
| 38.5
| null | 2.199707
| 10.298828
| 3.199707
| 126
| null | null | null | null | 4
| null |
<2 mo. follow-up
| 3.183199
| 33
| 1
|
67.10699
|
female
| 0
| 16
|
Lung Cancer
|
Cancer
| 1
| 9
| null | 9
| 16,886.344
| 12,085.1406
| null | 13
|
white
| 24.199219
| 26
| 0.487976
| 0.168976
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.2
|
dnr after sadm
| 5
| 103
| 6.5
| 92
| 24
| 38.09375
| 137.5
| null | null | 0.599976
| 129
| 7.539062
| null | null | null | 5
| 1
|
adl>=4 (>=5 if sur)
| 1
| 87
| 1
|
56.08798
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 9
|
$25-$50k
| 0
| 3,525.949
| 3,032.9102
| null | 4.5
|
white
| 17.296875
| 17
| 0.845947
| 0.745972
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 7
| 83
| 3.199707
| 80
| 20
| 36.5
| null | 3
| 3.5
| 0.899902
| 134
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,777
| 0
|
32.73898
|
male
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 61
| 164,466.375
| 108,297.125
| null | 45.75
|
white
| 39.898438
| 50
| 0.31897
| 0.204987
| 3
| 0
| 0
|
no
| 0.25
| 0.25
|
no dnr
| 45
| 49
| 15.798828
| 148
| 15
| 39.29688
| 113.32812
| null | 3.799805
| 1.199951
| 132
| 7.459961
| null | null | null | null | 1
| null | 1
| 1,777
| 0
|
69.09796
|
male
| 1
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$11-$25k
| 0
| 109,626.688
| 73,472.5
| null | 52.333313
|
white
| 46.695313
| 63
| 0.115997
| 0.022999
| 46
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 16
| 43
| 25.5
| 175
| 23
| 38.39844
| 160.84375
| 2.899902
| null | 1.199951
| 141
| 7.399414
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 16
| 1
|
65.27594
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 6,469.598
| 4,429.7188
| null | 8.5
|
white
| 18.097656
| 13
| 0.800903
| 0.577881
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 7
| 100
| 6.099609
| 76
| 16
| 36
| null | 3.299805
| 0.399963
| 0.699951
| 142
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 852
| 1
|
67.77295
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 3,056.35
| 2,487.2656
| null | 7
|
white
| 20.097656
| 16
| 0.849976
| 0.753906
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 5
| 73
| 18.5
| 100
| 16
| 35.69531
| 340
| null | null | 1.099854
| 139
| 7.329102
| null | null | null | 3
| 0
|
no(M2 and SIP pres)
| 0
| 541
| 1
|
77.80194
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 2,793.549
| 2,199.8731
| null | 4
|
white
| 42.898438
| 28
| 0.040993
| 0
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
dnr after sadm
| 1
| 110
| null | 84
| 20
| 36.09375
| null | 1
| null | null | 140
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
35.84399
|
female
| 0
| 48
|
Coma
|
Coma
| 0
| 17
|
>$50k
| 44
| 82,952.688
| 57,020.7188
| null | 23.75
|
white
| 19.5
| 16
| 0.807983
| 0.769897
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 48
| 75
| 18.398438
| 130
| 7
| 38
| 396
| null | 0.5
| 0.899902
| 137
| 7.479492
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,775
| 0
|
77.93799
|
male
| 1
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 11
|
$25-$50k
| 0
| 6,770.699
| 5,212.8438
| null | 11.5
|
white
| 27.699219
| 51
| 0.690918
| 0.525879
| 1
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 6
| 73
| 4.799805
| 156
| 28
| 35.89844
| null | 3.299805
| 1.599854
| 1.799805
| 145
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 9
| 1
|
56.51199
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 11,222.547
| 8,539.25
| null | 10.5
|
white
| 28.5
| 29
| 0.62793
| 0.314941
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 13
| 89
| 8.798828
| 98
| 20
| 35.19531
| null | 3.199707
| 0.599976
| 3.199707
| 138
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
66.91595
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 5,290.047
| 3,335.4199
| null | 15
|
white
| 9.898438
| 11
| 0.820923
| 0.613892
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 5
| 80
| 7.799805
| 76
| 20
| 36.69531
| null | 3.799805
| 0.299988
| 1.199951
| 143
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 388
| 1
|
58.94299
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 10
|
under $11k
| 0
| 6,483.449
| 5,730.9727
| null | 16
|
white
| 15.099609
| 14
| 0.915894
| 0.858887
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 6
| 65
| 9.898438
| 80
| 20
| 36.29688
| 323.75
| null | null | 1.199951
| 140
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 215
| 1
|
68.16394
|
male
| 1
| 3
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 6,288.598
| 4,459.4961
| null | 20
|
black
| 32.898438
| 36
| 0.27594
| 0.040993
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
no dnr
| 3
| 157
| 4.299805
| 20
| 48
| 35.79688
| 308.5625
| 2.899902
| 0.299988
| 0.799927
| 137
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.474609
| 3
| 1
|
63.41998
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
| null | 0
| 17,999.094
| 12,834.7578
| null | 19.5
|
black
| 21.898438
| 33
| 0.845947
| 0.746948
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 11
| 70
| 4.099609
| 44
| 22
| 36.09375
| 264
| null | 0.5
| 1.899902
| 137
| 7.549805
| null | null | null | 3
| 4
|
no(M2 and SIP pres)
| 4
| 266
| 1
|
81.31696
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
| null | 0
| 4,875.238
| 3,819.4688
| null | 7
|
black
| 23.699219
| 34
| 0.75
| 0.605957
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 8
| 63
| 3.399902
| 66
| 16
| 36.09375
| null | 3.299805
| 0.199982
| 4.799805
| 147
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
69.17694
|
male
| 1
| 129
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 15
|
>$50k
| 0
| 398,248
| 272,052.25
| null | 46
|
white
| 32.398438
| 46
| 0.521973
| 0.32196
| 21
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 126
| 63
| 13.699219
| 110
| 32
| 36.59375
| 97
| null | 0.699951
| 1.299805
| 129
| 7.25
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 129
| 1
|
64.99695
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 7,358.797
| 5,338.8594
| null | 3.5
|
white
| 16
| 24
| 0.897949
| 0.829956
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 100
| 6.099609
| 78
| 20
| 36.39844
| null | null | null | 1.5
| 144
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,770
| 0
|
25.62099
|
female
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 434,315.75
| 289,424
| null | 34.25
|
black
| 39.398438
| 42
| 0.595947
| 0.487976
| 73
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 30
| 139
| 16
| 138
| 28
| 36.29688
| 91.65625
| 2.699707
| 7.799805
| 1
| 150
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 45
| 1
|
42.20398
|
male
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 16
|
>$50k
| 0
| 8,795.25
| 6,635.2422
| null | 11
|
white
| 28.097656
| 31
| 0.765991
| 0.628906
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 10
| 97
| 5.399414
| 72
| 28
| 38.59375
| null | 2.299805
| 5.899414
| 0.799927
| 120
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,768
| 0
|
52.375
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
under $11k
| 0
| 20,454.188
| 15,171.6953
| null | 9.333328
|
black
| 16.796875
| 28
| 0.903931
| 0.868896
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 15
| 101
| 16.796875
| 80
| 24
| 38.09375
| 270
| 1.899902
| 2.699707
| 0.699951
| 138
| 7.40918
| null | null | null | 4
| 4
|
no(M2 and SIP pres)
| 4
| 185
| 1
|
57.86398
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 44
| 96,380.75
| 65,349.2812
| null | 32.25
|
white
| 28.097656
| 44
| 0.613892
| 0.508911
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 38
| 75
| 14.199219
| 62
| 42
| 36.39844
| 96.65625
| 1.199951
| 0.199982
| 0.799927
| 146
| 7.459961
| null | null | null | null | 1
|
SIP>=30
| 1
| 1,767
| 0
|
55.086
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 5,840.5
| 4,412.2109
| null | 9.5
|
white
| 17.097656
| 10
| 0.727905
| 0.455994
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 8
| 80
| 2.299805
| 78
| 20
| 37.69531
| null | 3.199707
| 1
| 0.899902
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 231
| 1
|
68.22699
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
under $11k
| 0
| 112,743.062
| 74,369.5625
| null | 32
|
white
| 24.296875
| 41
| 0.741943
| 0.660889
| 7
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 32
| 134
| 10.199219
| 110
| 40
| 38.09375
| 183.3125
| 4.099609
| 0.799927
| 0.699951
| 145
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 661
| 1
|
71.61694
|
male
| 0
| 52
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
| null | 0
| 153,677
| 106,389.438
| null | 22.5
|
white
| 25.597656
| 28
| 0.689941
| 0.5979
| 11
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 52
| 110
| 35.398438
| 130
| 7
| 36.39844
| 306.625
| null | null | 1.899902
| 139
| 7.349609
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.672852
| 440
| 1
|
54.44199
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 19,789.594
| 13,315.1406
| null | 13
|
white
| 40
| 65
| 0.259949
| 0.153992
| 8
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
dnr after sadm
| 4
| 126
| 26.699219
| 176
| 44
| 38.09375
| 124
| null | 5.399414
| 0.699951
| 126
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 2.606934
| 4
| 1
|
68.59399
|
female
| 1
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 6
| null | 0
| 58,190.719
| 38,401.9062
| null | 35.666657
|
black
| 33.195313
| 38
| 0.625
| 0.439941
| 1
| 1
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 17
| 61
| 19.796875
| 108
| 27
| 35.59375
| 404
| null | null | 1.899902
| 124
| 7.5
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
69.72998
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 6
| null | 0
| 3,366.648
| 2,877.0449
| null | 9
|
white
| 26.796875
| 24
| 0.750977
| 0.606934
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 69
| 5.699219
| 66
| 16
| 36.89844
| null | 2.699707
| 3.399902
| 0.799927
| 127
| null | null | null | null | 1
| 0
|
SIP>=30
| 0
| 1,034
| 1
|
41.40698
|
male
| 0
| 44
|
Coma
|
Coma
| 0
| 16
|
$25-$50k
| 94
| 154,288.875
| 104,675.625
| null | 33.25
|
black
| 37.796875
| 67
| 0.102997
| 0.061996
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 44
| 65
| 15.898438
| 180
| 20
| 38.29688
| 133.3125
| 2.599609
| 5.599609
| 4.5
| 151
| 7.439453
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 209
| 1
|
63.87097
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 48,938.531
| 34,675.1875
| null | 31.333328
|
white
| 38.5
| 78
| 0.507935
| 0.390991
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 107
| 9.099609
| 162
| 28
| 35
| 309.5
| null | 13.199219
| 5.199219
| 138
| 7.40918
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 229
| 1
|
46.72998
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 6,932.848
| 4,561.1914
| null | 10
|
white
| 15.5
| 11
| 0.863892
| 0.696899
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.3
|
no dnr
| 6
| 107
| 7.5
| 96
| 20
| 37.29688
| null | null | 0.899902
| 1.099854
| 134
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 134
| 1
|
45.36899
|
female
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 6,296.898
| 4,840.4023
| null | 7.5
|
white
| 31.398438
| 22
| 0.397949
| 0.10199
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 9
| 70
| 10.599609
| 110
| 24
| 38.09375
| null | 2.199707
| 0.399963
| 1
| 136
| null | null | null | null | 3
| null | null | 2.511099
| 60
| 1
|
61.42398
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 85,084.125
| 55,237.1562
| null | 39.666657
|
white
| 29.699219
| 43
| 0.695923
| 0.60498
| 3
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 6
| 61
| 10
| 126
| 32
| 38.79688
| 127.14062
| null | 1.599854
| 1.199951
| 131
| 7.359375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
51.56699
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| null | null | 94
| 22,312.328
| 15,496.0078
| null | 32
|
white
| 20.597656
| 21
| 0.286987
| 0.21698
| 9
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 119
| 18.199219
| 132
| 12
| 39.29688
| 228
| 3
| 0.5
| 0.899902
| 138
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.317871
| 4
| 1
|
43.625
|
female
| 0
| 134
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$25-$50k
| 0
| 401,867
| 269,131.25
| null | 42.5
|
white
| 26.097656
| 46
| 0.81897
| 0.758911
| 4
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 134
| 135
| 21.398438
| 130
| 26
| 37.59375
| 250
| null | 0.799927
| 9
| 143
| 7.449219
| null | null | null | 7
| 6
|
adl>=4 (>=5 if sur)
| 6
| 1,759
| 0
|
38.67999
|
male
| 1
| 8
|
Coma
|
Coma
| 2
| null | null | 100
| 71,634.188
| 46,963.0625
| null | 43
|
white
| 26.296875
| 50
| 0.312988
| 0.240997
| 8
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 8
| 136
| 25
| 108
| 8
| 36
| 330
| 1.899902
| null | 8
| 145
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.788574
| 8
| 1
|
66.84497
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 37
| 77,906.438
| 52,351.8438
| null | 41
|
white
| 38
| 62
| 0.118988
| 0.051994
| 25
| 1
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 5
| 105
| 24.699219
| 118
| 25
| 36.5
| 370
| 3
| 8.199219
| 2.799805
| 129
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 3.1875
| 6
| 1
|
58.56497
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 9
|
under $11k
| 0
| 18,640.047
| 13,730.0547
| null | 15.666664
|
black
| 27.296875
| 38
| 0.780884
| 0.708984
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 14
| 78
| 24.898438
| 62
| 10
| 35.09375
| 217.125
| null | 1.399902
| 2.299805
| 134
| 7.389648
| null | null | null | 2
| null | null | 1.839
| 437
| 1
|
59.42798
|
female
| 0
| 88
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 284,272
| 195,666.125
| null | 32
|
white
| 24.199219
| 46
| 0.767944
| 0.692993
| 12
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 88
| 59
| 24.199219
| 122
| 40
| 38.59375
| 263.3125
| null | 1.399902
| 1.199951
| 145
| 7.349609
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,757
| 0
|
35.62198
|
female
| 0
| 67
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 100
| 200,353.75
| 132,550.25
| null | 46.25
|
white
| 29.097656
| 36
| 0.434998
| 0.314941
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 67
| 131
| 14.599609
| 108
| 12
| 39.19531
| 240
| null | 12.099609
| 0.899902
| 156
| 7.5
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 1,757
| 0
|
66.94299
|
male
| 0
| 24
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 25,465.234
| 18,399.7969
| null | 15
|
white
| 20.296875
| 20
| 0.630981
| 0.31897
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 24
| 85
| 6.199219
| 116
| 24
| 35.69531
| null | null | 0.599976
| 1.199951
| 141
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 59
| 1
|
54.995
|
male
| 0
| 19
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$25-$50k
| 0
| 22,609.641
| 16,044.7812
| null | 16.666656
|
white
| 23.5
| 36
| 0.852905
| 0.757935
| 1
| 0
| 0
|
no
| 0.7
| 0.2
|
no dnr
| 19
| 57
| 8.398438
| 65
| 16
| 35.29688
| null | null | null | 2
| 136
| null | null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 29
| 1
|
60.51199
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 5,159.949
| 3,466.8379
| null | 11
|
white
| 18.898438
| 16
| 0.679932
| 0.383972
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 5
| 73
| 6.699219
| 110
| 16
| 36.89844
| null | null | 0.399963
| 0.599976
| 137
| null | null | null | null | 1
| 4
|
no(M2 and SIP pres)
| 4
| 369
| 1
|
57.84299
|
female
| 0
| 23
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 23,635.938
| 17,293.25
| null | 14.666664
|
white
| 26.398438
| 42
| 0.690918
| 0.524902
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 77
| 12.5
| 80
| 18
| 36.19531
| 442.8125
| 2.599609
| 4.799805
| 4.099609
| 138
| 7.379883
| null | null | null | 2
| 0
| null | 0
| 69
| 1
|
41.42899
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| 12,460.844
| 8,586.1641
| null | 8
|
black
| 20.597656
| 31
| 0.888916
| 0.849976
| 3
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 6
| 107
| 5.699219
| 108
| 22
| 37.69531
| 390.4375
| 3.399902
| 0.899902
| 12.398438
| 144
| 7.319336
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,754
| 0
|
60.06
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
$25-$50k
| 94
| 29,518.891
| 20,163.7969
| null | 44
|
white
| 43
| 74
| 0.011
| 0.002
| 8
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 4
| 61
| 31.5
| 126
| 30
| 38
| 137.75
| null | 19.5
| 4.599609
| 145
| 7.539062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
73.19397
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 60,910.531
| 42,843.3125
| null | 18.75
|
white
| 24.199219
| 19
| 0.703979
| 0.613892
| 15
| 0
| 0
|
no
| 0.4
| 0.6
|
no dnr
| 25
| 80
| 13.699219
| 114
| 24
| 36
| 200
| null | null | 1.299805
| 136
| 7.459961
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,754
| 0
|
53.63998
|
male
| 1
| 8
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 6,536.648
| 4,897.7344
| null | 11.5
|
black
| 31.398438
| 25
| 0.369995
| 0.084991
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 8
| 83
| 10.798828
| 120
| 28
| 36.29688
| 280.9375
| 2.799805
| 0.699951
| 1
| 132
| 7.389648
| null | null | null | 3
| null |
<2 mo. follow-up
| 2.511099
| 8
| 1
|
74.68298
|
female
| 1
| 4
|
Coma
|
Coma
| 1
| 6
|
under $11k
| 55
| 11,897.195
| 8,313.8281
| null | 24
|
black
| 43.5
| 73
| 0
| 0
| 4
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 131
| 18.199219
| 116
| 36
| 36
| 304
| null | 23.597656
| 2.099609
| 125
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
73.862
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 37,997.719
| 25,638.7812
| null | 13.333328
|
white
| 19
| 19
| 0.80896
| 0.744995
| 6
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 14
| 123
| 9.798828
| 82
| 20
| 36.09375
| 176.65625
| null | null | 1
| 136
| 7.479492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,750
| 0
|
72.12299
|
male
| 1
| 19
|
Coma
|
Coma
| 2
| 12
|
under $11k
| 0
| 70,576.5
| 47,851.1562
| null | 34.333313
|
black
| 24.199219
| 47
| 0.557983
| 0.48999
| 6
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 11
| 109
| 15.398438
| 82
| 75
| 39.09375
| 185
| 2.199707
| 0.699951
| 1.799805
| 145
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
58.52197
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$25-$50k
| 0
| 21,888.344
| 14,721.5156
| null | 19.5
|
white
| 22.199219
| 30
| 0.856934
| 0.763916
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 12
| 67
| 8.298828
| 118
| 26
| 36.19531
| null | null | 0.699951
| 1.399902
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 570
| 1
|
60.84598
|
male
| 0
| 18
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 16
|
>$50k
| 9
| 14,564.594
| 11,304.0547
| null | 7.333332
|
white
| 24.398438
| 32
| 0.67688
| 0.505981
| 1
| 1
| 0
|
no
| 0.99
| 0.970299
|
no dnr
| 18
| 80
| 6.899414
| 106
| 24
| 39.09375
| 347.5625
| 1.899902
| 3.899902
| 0.799927
| 127
| 7.479492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 644
| 1
|
59.85498
|
male
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 53,360.844
| 37,548.1562
| null | 17.5
|
black
| 25.699219
| 31
| 0.681885
| 0.587891
| 4
| 0
| 0
|
no
| 1
| 0.95
|
no dnr
| 36
| 101
| 20.296875
| 110
| 12
| 36.19531
| 322.1875
| 2.5
| null | 1.699951
| 146
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.025391
| 1,747
| 0
|
67.047
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
$11-$25k
| 0
| 21,429.297
| 15,346.4453
| null | 12.333328
|
white
| 25
| 9
| 0.758911
| 0.682983
| 3
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 17
| 118
| 11.699219
| 84
| 24
| 36.19531
| 215
| null | null | 0.5
| 127
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,746
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.